A Proteomics-Based Comparison of Host Responses to Spotted Fever Group Rickettsia in Endothelial Cells
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Spotted fever group (SFG) Rickettsia species are obligate intracellular bacteria with a tropism for endothelial cells (ECs), where they initiate pathogenesis leading to rickettsial vasculitis. However, how endothelial cells sense and respond to infection by Rickettsia species of differing pathogenic potential remains poorly defined. In this study, we conducted a comparative analysis of four SFG Rickettsia species - R. africae , R. parkeri , R. massiliae , and R. montanensis - using high-throughput label-free SWATH/DIA-MS/MS in human HUVEC/TERT2 cells. Our results revealed distinct intracellular growth dynamics that correlated with known virulence profiles: the more pathogenic R. africae and R. parkeri replicated more efficiently, while the non-pathogenic R. montanensis failed to replicate. Proteomic profiling uncovered both shared and species-specific host responses, with a marked induction of proteins associated with type I interferon (IFN-I) signaling, particularly in response to R. africae and R. parkeri . Proteins typically involved in antiviral immunity, such as RIG-I, ISG15, IFITs, MX1, MX2, and OAS family members, were significantly accumulated, suggesting activation of cytosolic nucleic acid sensing pathways upon infection with pathogenic rickettsiae. ISGylation levels, however, remained low and varied depending on the species, pointing to complex regulatory mechanisms. Comparison with previous quantitative proteomics data in THP-1 macrophages revealed a conserved interferon signature, while also highlighting cell-type-specific responses. Overall, our findings demonstrate that endothelial cells activate innate immune pathways typically associated with antiviral defense upon Rickettsia infection. These immune signatures may serve as potential indicators of pathogenic potential and provide a foundation for identifying biomarkers and therapeutic targets in rickettsial diseases.